Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MINTEZOL

THIABENDAZOLE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MINTEZOL is listed in Drugs@FDA under application 016096 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient THIABENDAZOLE Form and strength TABLET, CHEWABLE;ORAL - 500MG Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2003-06-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview MINTEZOL is listed in Drugs@FDA under application 016096 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient THIABENDAZOLE Form and strength TABLET, CHEWABLE;ORAL - 500MG Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2003-06-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.